Development Of Novel Hsp Based Vaccine Candidate Molecule In Fusion With Il 22 With Enhanced Immunogenicity And Protective Efficacy Against Microbial Infections

Abstract

newline

Description

Keywords

Citation

item.page.endorsement

item.page.review

item.page.supplemented

item.page.referenced